The article and the lecture are about Acquired Immune Deficiency Syndrome (AIDS). They address affordability of proper medications in poor countries. The author explains that AIDS advocacy groups claim to be helping to get such medicines to the people who need them. The lecturer later casts doubt on these claims. 

     The article suggests that major pharmaceutical companies should provide medications at a lower price to those who live in squalor, since profits are considerably elevated. Nevertheless, the lecturer objects to this idea. He holds that pharmaceutical companies have to survive in the business world by making profits. No profits for the companies means that they would have to stop developing drugs.

     Secondly, according to the article, governments should buy medicines in large quantities in order to reduce costs. Buying individually is more expensive. However, the lecturer points out that poor countries have poor governments, so they couldn't afford these investments.

     Finally, the author belives that poor countries should create their own, cheaper versions of the AIDS medications, which would apparently increase employment rates while decreasing shipping costs. In contrast, the lecturer casts doubt upon his claim by explaining that this would be illegal as well as dangerous, and that this would consist in creating low-quality medications that could be fatal to patients.

     Word order; run-on sentences; proper jargon; errors in paralellism, yet interesting, Kris.